September 01, 2017

Cellavision

We feel like a lame duck on the markets.


CEVI.ST US4 (ISIN: SE0000683484)      

CellaVision AB is a Sweden-based company active in the medical technology sector. The Company develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education.

Market: Stockholm

http://www.cellavision.com


Loss over the last quarter: -5.5 % 


Fair value: 190 SEK
Discount: 17%
Average yearly return: 59%
Yield: 1.9%
Outperformer

July 18, 2017:Strong second quarter with growth and increased profitability

No comments:

Post a Comment